Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Operating Expenses | 50,049 | 49,923 | 40,917 | 39,716 | 40,185 |
| Operating Income | -50,049 | -49,923 | -40,917 | -39,716 | -40,185 |
| Interest Expense | 1,711 | 1,312 | 1,748 | 1,198 | 1,174 |
| Other Income | 2,744 | 1,055 | 335 | 375 | 507 |
| Pre-tax Income | -49,016 | -50,180 | -42,330 | -40,539 | -40,852 |
| Net Income Continuous | -49,016 | -50,180 | -42,330 | -40,539 | -40,852 |
| Net Income | $-49,016 | $-50,180 | $-42,330 | $-40,539 | $-40,852 |
| EPS Basic Total Ops | -0.55 | -0.56 | -0.51 | -0.50 | -0.51 |
| EPS Basic Continuous Ops | -0.55 | -0.56 | -0.51 | -0.50 | -0.51 |
| EPS Diluted Total Ops | -0.55 | -0.56 | -0.51 | -0.50 | -0.51 |
| EPS Diluted Continuous Ops | -0.55 | -0.56 | -0.51 | -0.50 | -0.51 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -0.56 | -0.51 | N/A | N/A |
| EBITDA(a) | $-48,730 | $-48,407 | $-39,421 | $-39,201 | $-38,574 |